Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Stifel analyst Michael Hoffman maintains Charah Solns (NYSE:CHRA) with a Buy, adjusts price target to $17 - 1-for-10 reverse stock split.
Posted In: CHRA